APA (7th ed.) Citation

Y, K., T, K., T, W., T, N., M, T., D, Y., . . . S, M. (2025). Usefulness of hepatic CT attenuation values in assessment of Fontan-associated liver disease progression: A comparative study with Model of End-stage Liver Disease Excluding International Normalized Ratio scores. Cardiology in the young, 35(4), 831. https://doi.org/10.1017/S1047951125000393

Chicago Style (17th ed.) Citation

Y, Kugo, Kido T, Watanabe T, Nagashima T, Taira M, Yoshioka D, Shimamura K, and Miyagawa S. "Usefulness of Hepatic CT Attenuation Values in Assessment of Fontan-associated Liver Disease Progression: A Comparative Study with Model of End-stage Liver Disease Excluding International Normalized Ratio Scores." Cardiology in the Young 35, no. 4 (2025): 831. https://doi.org/10.1017/S1047951125000393.

MLA (9th ed.) Citation

Y, Kugo, et al. "Usefulness of Hepatic CT Attenuation Values in Assessment of Fontan-associated Liver Disease Progression: A Comparative Study with Model of End-stage Liver Disease Excluding International Normalized Ratio Scores." Cardiology in the Young, vol. 35, no. 4, 2025, p. 831, https://doi.org/10.1017/S1047951125000393.